FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Stem cells and development2010; 20(4); 721-735; doi: 10.1089/scd.2010.0175

Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow.

Abstract: A long-term goal of mesenchymal progenitor cell (MPC) research is to identify cell-surface markers to facilitate MPC isolation. One reported MPC feature in humans and other species is lack of CD14 (lipopolysaccharide receptor) expression. The aim of this study was to evaluate CD14 as an MPC sorting marker. Our hypothesis was that cells negatively selected by CD14 expression would enrich MPC colony formation compared with unsorted and CD14-positive fractions. After validation of reagents, bone marrow aspirate was obtained from 12 horses. Fresh and cultured cells were analyzed by flow cytometry and reverse transcription and quantitative polymerase chain reaction to assess dynamic changes in phenotype. In fresh samples, cells did not consistently express protein markers used for lineage classification. Short-term (2-day) culture allowed distinction between hematopoietic and nonhematopoietic populations. Magnetic activated cell sorting was performed on cells from 6 horses to separate adherent CD14(+) from CD14(-) cells. MPC colony formation was assessed at 7 days. Cells positively selected for CD14 expression were significantly more likely to form MPC colonies than both unsorted and negatively selected cells (P ≤ 0.005). MPCs from all fractions maintained low levels of CD14 expression long term, and upregulated CD14 gene and protein expression when stimulated with lipopolysaccharide. The equine CD14 molecule was trypsin-labile, offering a plausible explanation for the discrepancy with MPC phenotypes reported in other species. By definition, MPCs are considered nonhematopoietic because they lack expression of molecules such as CD14. Our results challenge this assumption, as equine MPCs appear to represent a descendant of a CD14-positive cell.
Get Full Text
Publication Date: 2010-10-12 PubMed ID: 20722500PubMed Central: PMC3128771DOI: 10.1089/scd.2010.0175Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the role of CD14, a receptor protein, in identifying and isolating Mesenchymal Progenitor Cells (MPCs) from horse bone marrow. Whilst CD14 is commonly absent in MPCs in humans, the study found that in equine MPCs, those cells that were selected based on the presence of CD14 were more likely to form colonies, challenging previous biological assumptions.

Research Purpose and Hypothesis

  • The study aimed to assess the potential of CD14, a lipopolysaccharide receptor, as a marker for sorting Mesenchymal Progenitor Cells (MPCs). MPCs are a type of stem cell with huge potential for tissue repair and regeneration.
  • In humans and other species, CD14 is not typically expressed on MPCs. The researchers hypothesized that by selecting cells that did not express CD14, they would enrich the formation of MPC colonies when compared with unsorted or CD14-positive cells.

Methodology

  • Bone marrow aspirate was obtained from 12 horses and both fresh and cultured cells were analysed using flow cytometry and reverse transcription and quantitative polymerase chain reaction. These techniques allowed researchers to track changes in cell phenotype, or observable characteristics.
  • Cells were sorted using magnetic activated cell sorting. This process involved isolating CD14(+) cells from CD14(-) cells in order to assess MPC colony formation at seven days.

Results and Findings

  • The results showed that cells which were positively selected for CD14 expression were significantly more likely to form MPC colonies than those that were unsorted or negatively selected.
  • In the resulting MPCs, low levels of CD14 expression were maintained over a long period of time. Moreover, CD14 gene and protein expression were upregulated when the cells were stimulated with lipopolysaccharide.
  • The researchers found that the equine CD14 molecule was trypsin-labile, meaning that it could be broken down by trypsin, a digestive enzyme. This could explain why the findings of this study differ from the typical MPC phenotypes found in other species.

Conclusions

  • According to the standard definition, MPCs do not express CD14 and are considered nonhematopoietic. However, this study suggests that equine MPCs could potentially originate from a CD14-positive cell. This discovery challenges previous assumptions and increases our understanding of the complex nature of progenitor cells.

Cite This Article

APA
Hackett CH, Flaminio MJ, Fortier LA. (2010). Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow. Stem Cells Dev, 20(4), 721-735. https://doi.org/10.1089/scd.2010.0175

Publication

Stem cells and development
ISSN: 1557-8534
NlmUniqueID: 101197107
Country: United States
Language: English
Volume: 20
Issue: 4
Pages: 721-735

Researcher Affiliations

Hackett, Catherine H
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Flaminio, Maria Julia B F
    Fortier, Lisa A

      MeSH Terms

      • Animals
      • Antibody Specificity
      • Antigens, Differentiation / genetics
      • Antigens, Differentiation / metabolism
      • Blotting, Western
      • Bone Marrow Cells / cytology
      • Bone Marrow Cells / metabolism
      • Cell Separation / methods
      • Colony-Forming Units Assay
      • Flow Cytometry
      • Horses
      • Lipopolysaccharide Receptors / metabolism
      • Lipopolysaccharides / pharmacology
      • Membrane Proteins / genetics
      • Membrane Proteins / metabolism
      • Mesenchymal Stem Cells / metabolism
      • Protein Biosynthesis / drug effects
      • Transcription, Genetic
      • Trypsin / pharmacology

      Grant Funding

      • T32RR07059 / NCRR NIH HHS

      References

      This article includes 21 references
      1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
        pubmed: 16923606doi: 10.1080/14653240600855905google scholar: lookup
      2. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, Ikeda Y. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation.. J Leukoc Biol 2003 Nov;74(5):833-45.
        pubmed: 12960274doi: 10.1189/jlb.0403170google scholar: lookup
      3. Kodama H, Inoue T, Watanabe R, Yasuoka H, Kawakami Y, Ogawa S, Ikeda Y, Mikoshiba K, Kuwana M. Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes.. Stem Cells Dev 2005 Dec;14(6):676-86.
        pubmed: 16433623doi: 10.1089/scd.2005.14.676google scholar: lookup
      4. Pufe T, Petersen W, Fändrich F, Varoga D, Wruck CJ, Mentlein R, Helfenstein A, Hoseas D, Dressel S, Tillmann B, Ruhnke M. Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes.. J Orthop Res 2008 Mar;26(3):304-13.
        pubmed: 17963214doi: 10.1002/jor.20516google scholar: lookup
      5. Sera Y, LaRue AC, Moussa O, Mehrotra M, Duncan JD, Williams CR, Nishimoto E, Schulte BA, Watson PM, Watson DK, Ogawa M. Hematopoietic stem cell origin of adipocytes.. Exp Hematol 2009 Sep;37(9):1108-20, 1120.e1-4.
        pmc: PMC2740899pubmed: 19576951doi: 10.1016/j.exphem.2009.06.008google scholar: lookup
      6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells.. Science 1999 Apr 2;284(5411):143-7.
        pubmed: 10102814doi: 10.1126/science.284.5411.143google scholar: lookup
      7. Ringe J, Leinhase I, Stich S, Loch A, Neumann K, Haisch A, Häupl T, Manz R, Kaps C, Sittinger M. Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering.. J Tissue Eng Regen Med 2008 Mar-Apr;2(2-3):136-46.
        pubmed: 18383554doi: 10.1002/term.75google scholar: lookup
      8. Sung JH, Yang HM, Park JB, Choi GS, Joh JW, Kwon CH, Chun JM, Lee SK, Kim SJ. Isolation and characterization of mouse mesenchymal stem cells.. Transplant Proc 2008 Oct;40(8):2649-54.
        pubmed: 18929828doi: 10.1016/j.transproceed.2008.08.009google scholar: lookup
      9. Han K, Lee JE, Kwon SJ, Park SY, Shim SH, Kim H, Moon JH, Suh CS, Lim HJ. Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy.. Cell Prolif 2008 Oct;41(5):709-25.
        pmc: PMC6496450pubmed: 18823496doi: 10.1111/j.1365-2184.2008.00553.xgoogle scholar: lookup
      10. You Q, Cai L, Zheng J, Tong X, Zhang D, Zhang Y. Isolation of human mesenchymal stem cells from third-trimester amniotic fluid.. Int J Gynaecol Obstet 2008 Nov;103(2):149-52.
        pubmed: 18760782doi: 10.1016/j.ijgo.2008.06.012google scholar: lookup
      11. Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Guérin JJ, Pigeon P, Descamps S, Boisgard S, Berger MG. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow.. Exp Hematol 2005 Feb;33(2):219-25.
        pubmed: 15676216doi: 10.1016/j.exphem.2004.11.001google scholar: lookup
      12. Jo CH, Ahn HJ, Kim HJ, Seong SC, Lee MC. Surface characterization and chondrogenic differentiation of mesenchymal stromal cells derived from synovium.. Cytotherapy 2007;9(4):316-27.
        pubmed: 17573607doi: 10.1080/14653240701291620google scholar: lookup
      13. Maurice S, Srouji S, Livne E. Isolation of progenitor cells from cord blood using adhesion matrices.. Cytotechnology 2007 Jun;54(2):121-33.
        pmc: PMC2267502pubmed: 19003027doi: 10.1007/s10616-007-9077-0google scholar: lookup
      14. Radcliffe CH, Flaminio MJ, Fortier LA. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.. Stem Cells Dev 2010 Feb;19(2):269-82.
        pmc: PMC3138180pubmed: 19604071doi: 10.1089/scd.2009.0091google scholar: lookup
      15. Bryniarski K, Maresz K, Szczepanik M, Ptak M, Ptak W. Modulation of macrophage activity by proteolytic enzymes. Differential regulation of IL-6 and reactive oxygen intermediates (ROIs) synthesis as a possible homeostatic mechanism in the control of inflammation.. Inflammation 2003 Dec;27(6):333-40.
        pubmed: 14760941doi: 10.1023/b:ifla.0000006701.52150.43google scholar: lookup
      16. Flaminio MJ, Rush BR, Shuman W. Peripheral blood lymphocyte subpopulations and immunoglobulin concentrations in healthy foals and foals with Rhodococcus equi pneumonia.. J Vet Intern Med 1999 May-Jun;13(3):206-12.
        pubmed: 10357110doi: 10.1892/0891-6640(1999)013<0206:pblsai>2.3.co;2google scholar: lookup
      17. Kabithe E, Hillegas J, Stokol T, Moore J, Wagner B. Monoclonal antibodies to equine CD14.. Vet Immunol Immunopathol 2010 Nov 15;138(1-2):149-53.
        pubmed: 20674042doi: 10.1016/j.vetimm.2010.07.003google scholar: lookup
      18. Mauel S, Steinbach F, Ludwig H. Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice.. Immunology 2006 Apr;117(4):463-73.
        pmc: PMC1782256pubmed: 16556260doi: 10.1111/j.1365-2567.2005.02319.xgoogle scholar: lookup
      19. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.. J Mol Endocrinol 2000 Oct;25(2):169-93.
        pubmed: 11013345doi: 10.1677/jme.0.0250169google scholar: lookup
      20. Goidin D, Mamessier A, Staquet MJ, Schmitt D, Berthier-Vergnes O. Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations.. Anal Biochem 2001 Aug 1;295(1):17-21.
        pubmed: 11476540doi: 10.1006/abio.2001.5171google scholar: lookup
      21. McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells.. J Cell Physiol 2009 May;219(2):324-33.
        pubmed: 19115243doi: 10.1002/jcp.21670google scholar: lookup

      Citations

      This article has been cited 9 times.
      1. Hagen A, Lehmann H, Aurich S, Bauer N, Melzer M, Moellerberndt J, Patané V, Schnabel CL, Burk J. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture. Front Bioeng Biotechnol 2020;8:613621.
        doi: 10.3389/fbioe.2020.613621pubmed: 33553119google scholar: lookup
      2. Twomey-Kozak J, Desai S, Liu W, Li NY, Lemme N, Chen Q, Owens BD, Jayasuriya CT. Distal-Less Homeobox 5 Is a Therapeutic Target for Attenuating Hypertrophy and Apoptosis of Mesenchymal Progenitor Cells. Int J Mol Sci 2020 Jul 8;21(14).
        doi: 10.3390/ijms21144823pubmed: 32650430google scholar: lookup
      3. Contentin R, Demoor M, Concari M, Desancé M, Audigié F, Branly T, Galéra P. Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering. Stem Cell Rev Rep 2020 Feb;16(1):126-143.
        doi: 10.1007/s12015-019-09914-2pubmed: 31745710google scholar: lookup
      4. Park HJ, Lee WY, Park C, Hong K, Song H. CD14 is a unique membrane marker of porcine spermatogonial stem cells, regulating their differentiation. Sci Rep 2019 Jul 10;9(1):9980.
        doi: 10.1038/s41598-019-46000-6pubmed: 31292454google scholar: lookup
      5. Du L, Yang P, Ge S. Isolation and characterization of human gingiva-derived mesenchymal stem cells using limiting dilution method. J Dent Sci 2016 Sep;11(3):304-314.
        doi: 10.1016/j.jds.2016.03.010pubmed: 30894989google scholar: lookup
      6. Cortés-Araya Y, Amilon K, Rink BE, Black G, Lisowski Z, Donadeu FX, Esteves CL. Comparison of Antibacterial and Immunological Properties of Mesenchymal Stem/Stromal Cells from Equine Bone Marrow, Endometrium, and Adipose Tissue. Stem Cells Dev 2018 Nov 1;27(21):1518-1525.
        doi: 10.1089/scd.2017.0241pubmed: 30044182google scholar: lookup
      7. Desancé M, Contentin R, Bertoni L, Gomez-Leduc T, Branly T, Jacquet S, Betsch JM, Batho A, Legendre F, Audigié F, Galéra P, Demoor M. Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy. Int J Mol Sci 2018 Feb 10;19(2).
        doi: 10.3390/ijms19020537pubmed: 29439436google scholar: lookup
      8. Delling U, Lindner K, Ribitsch I, Jülke H, Brehm W. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses. Can J Vet Res 2012 Jan;76(1):52-6.
        pubmed: 22754095
      9. Hackett CH, Greve L, Novakofski KD, Fortier LA. Comparison of gene-specific DNA methylation patterns in equine induced pluripotent stem cell lines with cells derived from equine adult and fetal tissues. Stem Cells Dev 2012 Jul 1;21(10):1803-11.
        doi: 10.1089/scd.2011.0055pubmed: 21988203google scholar: lookup
      Subscribe to our newsletter
      Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.